36254DMEMF12 with 15 mM HEPES and 4 more items

Virginia Commonwealth University has awarded a contract to StemCell Technologies Inc., effective September 8, 2026, with a cumulative value of $6,167.00. The contract, identified as A236_P0353272, calls for the delivery of specialized biological media and reagents to VCU Procurement in support of research operations. The contract encompasses five distinct line items comprising laboratory consumables essential for organoid research and development.

The deliverables include four units of 36254DMEMF12 with 15 millimolar HEPES buffer solution at $66 per unit, one unit of antiAdherence Rinsing Solution at $61, four units of Human Organoid Initiation Medium (OIM) at $772 per unit, one unit of Human Recombinant Epidermal Growth Factor (EGF) at $106, and four units of Human Organoid Growth Medium (OGM) at $662 per unit. These materials represent critical components for stem cell and organoid cultivation protocols. All items are designated for delivery to VCU Procurement, indicating the contract supports the university's research infrastructure and capabilities in regenerative medicine and cellular biology.